Loss of pRB and p107 disrupts cartilage development and promotes enchondroma formation

Oncogene

Volumn 32, Issue 40, 2013, Pages 4798-4805

  Landman, A S ^b   Danielian, P S ^b   Lees, J A ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cartilage; chondrocytes; enchondroma; p107; pRB; Prx1 Cre

Indexed keywords

PROTEIN P107; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CARTILAGE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; COORDINATION; EMBRYO; ENCHONDRAL OSSIFICATION; ENCHONDROMA; GENE MUTATION; GROWTH PLATE; MESENCHYME; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RAT;

ANIMALS; CHONDROGENESIS; CHONDROMA; GROWTH PLATE; MICE; MICE, KNOCKOUT; MUTATION; REAL-TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; TOMOGRAPHY, X-RAY COMPUTED;

MUS;

EID: 84885183132     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.496     Document Type: Article

References (51)

1. Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 1995; 75: 2186-2195.
2. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323-330.
3. Clarke AR, Maandag ER, Van Roon M, Van Der Lugt NM, Van Der Valk M, Hooper ML et al. Requirement for a functional Rb-1 gene in murine Development. Nature 1992; 359: 328-330.
4. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. Effects of an Rb mutation in the mouse. Nature 1992; 359: 295-300.
5. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K et al. Mice de ficient for Rb are nonviable and show de fects in neurogenesis and haematopoiesis. Nature 1992; 359: 288-294.
6. Wu L, de bruin A, Saavedra HI, Starovic M, Trimboli A, Yang Y et al. Extraembryonic function of Rb is essential for embryonic Development and viability. Nature 2003; 421: 942-947.
7. Zacksenhaus E, Jiang Z, Chung D, Marth JD, Phillips RA, Gallie BL. pRb controls proliferation, differentiation, and Death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev 1996; 10: 3051-3064.
8. MacPherson D, Sage J, Crowley D, Trumpp A, Bronson RT, Jacks T. Conditional mutation of Rb causes cell cycle de fects without apoptosis in the central nervous system. Mol Cell Biol 2003; 23: 1044-1053.
9. Lipinski MM, Macleod KF, Williams BO, Mullaney TL, Crowley D, Jacks T. Cellautonomous and non-cell-autonomous functions of the Rb tumor suppressor in Developing central nervous system. EMBO J 2001; 20: 3402-3413.
10. Ferguson KL, Vanderluit JL, Hebert JM, McIntosh WC, Tibbo E, MacLaurin JG et al. Telencephalon-specific Rb knockouts reveal enhanced neurogenesis, survival and abnormal cortical Development. EMBO J 2002; 21: 3337-3346.
11. de bruin A, Wu L, Saavedra HI, Wilson P, Yang Y, Rosol TJ et al. Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb-deficient mice. Proc Natl Acad Sci USA 2003; 100: 6546-6551.
12. Dirlam A, Spike BT, Macleod KF. de regulated E2f-2 underlies cell cycle and maturation de fects in retinoblastoma null erythroblasts. Mol Cell Biol 2007; 27: 8713-8728.
13. Saavedra HI, Wu L, de bruin A, Timmers C, Rosol TJ, Weinstein M et al. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb. Cell Growth Differ 2002; 13: 215-225.
14. Tsai KY, Hu Y, Macleod KF, Crowley D, Yamasaki L, Jacks T. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rbdeficient mouse embryos. Mol Cell 1998; 2: 293-304.
15. Wenzel PL, Wu L, de bruin A, Chong JL, Chen WY, Dureska G et al. Rb is critical in a mammalian tissue stem cell population. Genes Dev 2007; 21: 85-97.
16. Ziebold U, Reza T, Caron A, Lees JA. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev 2001; 15: 386-391.
17. Trimarchi JM, Lees JA. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 2002; 3: 11-20.
18. Robanus-Maandag E, De kker M, Van Der Valk M, Carrozza ML, Jeanny JC, Dannenberg JH et al. p107 is a suppressor of retinoblastoma Development in pRb-deficient mice. Genes Dev 1998; 12: 1599-1609.
19. Berman SD, West JC, Danielian PS, Caron AM, Stone JR, Lees JA. Mutation of p107 exacerbates the consequences of Rb loss in embryonic tissues and causes cardiac and blood vessel de fects. Proc Natl Acad Sci USA 2009; 106: 14932-14936.
20. Sage J, Miller AL, Perez-Mancera PA, Wysocki JM, Jacks T. Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 2003; 424: 223-228.
21. Ruiz S, Santos M, Segrelles C, Leis H, Jorcano JL, Berns A et al. Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis. Development 2004; 131: 2737-2748.
22. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N et al. Shared role of the pRB-related p130 and p107 proteins in limb Development. Genes Dev 1996; 10: 1633-1644.
23. Rossi F, MacLean HE, Yuan W, Francis RO, Semenova E, Lin CS et al. p107 and p130 Coordinately regulate proliferation, Cbfa1 expression, and hypertrophic 271-285.
24. Scheijen B, Bronk M, Van Der Meer T, Bernards R. Constitutive E2F1 overexpression de lays endochondral bone formation by inhibiting chondrocyte differentiation. Mol Cell Biol 2003; 23: 3656-3668.
25. Danielian PS, Friesenhahn LB, Faust AM, West JC, Caron AM, Bronson RT et al. E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity. Oncogene 2008; 27: 6561-6570.
26. Tsai SY, Opavsky R, Sharma N, Wu L, Naidu S, Nolan E et al. Mouse Development with a single E2F activator. Nature 2008; 454: 1137-1141.
27. Calo E, Quintero-Estades JA, Danielian PS, Nedelcu S, Berman SD, Lees JA. Rb regulates fate choice and lineage commitment in vivo. Nature 2010; 466: 1110-1114.
28. Berman SD, Yuan TL, Miller ES, Lee EY, Caron A, Lees JA. The retinoblastoma protein tumor suppressor is important for appropriate osteoblast differentiation and bone Development. Mol Cancer Res 2008; 6: 1440-1451.
29. Gutierrez GM, Kong E, Sabbagh Y, Brown NE, Lee JS, de may MB et al. Impaired bone Development and increased mesenchymal progenitor cells in calvaria of RB1-/-mice. Proc Natl Acad Sci USA 2008; 105: 18402-18407.
30. Thomas DM, Carty SA, Piscopo DM, Lee JS, Wang WF, Forrester WC et al. The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol Cell 2001; 8: 303-316.
31. Logan M, Martin JF, Nagy A, Lobe C, Olson EN, Tabin CJ. Expression of Cre Recombinase in the Developing mouse limb bud driven by a Prxl enhancer. Genesis 2002; 33: 77-80.
32. Zheng Q, Keller B, Zhou G, Napierala D, Chen Y, Zabel B et al. Localization of the cis-enhancer element for mouse type X collagen expression in hypertrophic chondrocytes in vivo. J Bone Miner Res 2009; 24: 1022-1032.
33. Politi K, Szabolcs M, Fisher P, Kljuic A, Ludwig T, Efstratiadis A. A mouse model of uterine leiomyosarcoma. Am J Pathol 2004; 164: 325-336.
34. Miller MD. Review of Orthopaedics. 4th edn. Saunders: Philadelphia, PA, 2004, xv 704 pp.
35. Bovee JV, Hogendoorn PC, Wunder JS, Alman BA. Cartilage tumours and bone Development: Molecular pathology and possible therapeutic targets. Nat Rev Cancer 2010; 10: 481-488.
36. Kronenberg HM. Developmental regulation of the growth plate. Nature 2003; 423: 332-336.
37. Berman SD, Calo E, Landman AS, Danielian PS, Miller ES, West JC et al. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage. Proc Natl Acad Sci USA 2008; 105: 11851-11856.
38. Walkley CR, Qudsi R, Sankaran VG, Perry JA, Gostissa M, Roth SI et al. Conditional mouse osteosarcoma, de pendent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev 2008; 22: 1662-1676.
39. Sage C, Huang M, Vollrath MA, Brown MC, Hinds PW, Corey DP et al. Essential role of retinoblastoma protein in mammalian hair cell Development and hearing. Proc Natl Acad Sci USA 2006; 103: 7345-7350.
40. Asp J, Inerot S, Block JA, Lindahl A. Alterations in the regulatory pathway involving p16, pRb and cdk4 in human chondrosarcoma. J Orthop Res 2001; 19: 149-154.
41. Asp J, Sangiorgi L, Inerot SE, Lindahl A, Molendini L, Benassi MS et al. Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues. Int J Cancer 2000; 85: 782-786.
42. Yamaguchi T, Toguchida J, Wadayama B, Kanoe H, Nakayama T, Ishizaki K et al. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas. Anticancer Res 1996; 16: 2009-2015.
43. Ropke M, Boltze C, Meyer B, Neumann HW, Roessner A, Schneider-Stock R. Rb-loss is associated with high malignancy in chondrosarcoma. Oncol Rep 2006; 15: 89-95.
44. Boeuf S, Kunz P, Hennig T, Lehner B, Hogendoorn P, Bovee J et al. A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma. J Pathol 2008; 216: 158-166.
45. Tiet TD, Hopyan S, Nadesan P, Gokgoz N, Poon R, Lin AC et al. Constitutive hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation. Am J Pathol 2006; 168: 321-330.
46. Schrage YM, Hameetman L, Szuhai K, Cleton-Jansen AM, Taminiau AH, Hogendoorn PC et al. Aberrant heparan sulfate proteoglycan localization, de spite normal exostosin, in central chondrosarcoma. Am J Pathol 2009; 174: 979-988.
47. Yamasaki L, Bronson R, Williams BO, Dyson NJ, Harlow E, Jacks T. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(?/-)mice. Nat Genet 1998; 18: 360-364.
48. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999; 21: 70-71.
49. Parisi T, Yuan TL, Faust AM, Caron AM, Bronson R, Lees JA. Selective requirements for E2f3 in the Development and tumorigenicity of Rb-deficient chimeric tissues. Mol Cell Biol 2007; 27: 2283-2293.
50. Glatt V, Canalis E, Stadmeyer L, Bouxsein ML. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res 2007; 22: 1197-1207.
51. Lefebvre V, Garofalo S, Zhou G, Metsaranta M, Vuorio E, de crombrugghe B. Characterization of primary cultures of chondrocytes from type II collagen/betagalactosidase transgenic mice. Matrix Biol 1994; 14: 329-335.